2016 American Transplant Congress Archives - Page 43 of 180

6:00pm-7:00pm: Strategies to Prevent Ischemic Cholangiopathy After Donation After Circulatory Death Donor Liver Transplantation.

C. Kubal,¹ R. Mangus,¹ J. Fridell,¹ B. Ekser,¹ N. Rush,² R. Saxena,² J. Tector.¹

Poster Session B: Liver: MELD, Allocation and Donor Issues (DCD/ECD) • Halls C&D

6:00pm-7:00pm: Stratification of Kidney Transplant Recipients into Those with Low and High Alloreactive T-Cells May Allow Safe Conversion to mTOR-Inhibitor-Based Immunosuppression.

T. Schachtner,^1,2 M. Stein,² P. Reinke.^1,2

Poster Session B: Drug Minimization • Halls C&D

6:00pm-7:00pm: Successful Human-to-NonHuman Primate Pancreatic Islet Intraportal Xenotransplantation Using a Human Allo-Based Immunosuppression Regimen and Its Potential Pre-Clinical Application.

J. McGarrigle,¹ M. Bochenek,¹ E. Marchese,¹ A. Khan,¹ D. Gutierrez,^1,2 A. Mikalauskaite,¹ B. McCracken,¹ M. Reedy,¹ M. Omami,¹ C.-C. Yeh,¹ M. Spaggiari,¹ M. Nourmohammadzadeh,^1,2 D. Isa,¹ S. Ghani,¹ L.-J. Wang,¹ J. Mendoza-Elias,^1,2 Y. Wang,¹ J. Oberholzer.^1,2

Poster Session B: Allograft Rejection, Tolerance, and Xenotransplantation • Halls C&D

6:00pm-7:00pm: Survival Advantage in the Elderly with Kidney Transplantation.

G. Spanos,¹ N. Duncan,¹ P. Brookes,¹ D. Goodall,¹ K. Koutroutsos,¹ E. Evangelou,² M. Loucaidou.¹

Poster Session B: Disparities in Access and Outcomes • Halls C&D

6:00pm-7:00pm: Survival After Second Kidney Transplant: Are We Being Good Stewards?

C. Jay, J. Pugh, G. Halff, G. Abrahamian, F. Cigarroa, N. Stephens, K. Washburn.

Poster Session B: Kidney Transplantation: KDPI, HCV/Matching, Donor Age • Halls C&D

6:00pm-7:00pm: Survival Benefit from Kidney Transplantation Using Kidneys from Deceased Donors Over 75 Years.

M. Pérez-Sáez,¹ E. Arcos,² J. Comas,² M. Crespo,¹ J. Lloveras,¹ J. Tort,² J. Pascual,¹ Catalan Renal Registry Committee.²

Poster Session B: Kidney Transplantation: KDPI, HCV/Matching, Donor Age • Halls C&D

6:00pm-7:00pm: Survival Benefit of Kidney Transplantation in US Adults with Sickle Cell Nephropathy.

T. Purnell, X. Luo, S. Bae, A. Massie, D. Segev.

Poster Session B: Disparities in Access and Outcomes • Halls C&D

6:00pm-7:00pm: Susceptibility Patterns of Pre-Transplant Pseudomonas and Post-Lung Transplant Outcomes in Patients with Cystic Fibrosis.

S. Pouch,¹ E. Lease,² T. Bogdanovich,³ D. Ho,⁴ R. Miller,⁵ M. Estabrook,⁶ T. Babu,⁷ C. Kotton,⁷ C. Shaver,⁸ L. Thomas,⁸ S. Aslam,⁹ T. McCarty,¹⁰ J. Garcia-Diaz,¹¹ K. Doucette,¹² S. Kirkby,¹³ D. van Duin.¹⁴

Poster Session B: Lung Transplantation Posters • Halls C&D

6:00pm-7:00pm: Systematic Review and Meta-Analysis of the Impact of Computed Tomography Assessed Skeletal Muscle Mass on Outcome in Patients Awaiting or Undergoing Liver Transplantation.

J. van Vugt,¹ S. Levolger,¹ R. de Bruin,¹ J. van Rosmalen,² H. Metselaar,³ J. IJzermans.¹

Poster Session B: Liver: MELD, Allocation and Donor Issues (DCD/ECD) • Halls C&D

6:00pm-7:00pm: Th17 Development Is Critical for Airway Epithelial Injury After Transplantation.

J. Xu, Y. Zhang, L. Wang, X. Li, R. Chen, R. Zhang, Y. Ding.

Poster Session B: Allograft Rejection, Tolerance, and Xenotransplantation • Halls C&D